$329.96
Value $890B
JPM and OSG stock compared: price, dividend, valuation and results, from SEC filings.
$329.96
Value $890B
$4.95
Value $223M
JP Morgan Chase & Co. (JPM) has a market value of $890B and Octave Specialty (OSG) $223M. Over the last year, with dividends, JPM moved +10.8% and OSG -48.0%. Dividend yield: JPM 1.86%, OSG none.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
JPM$890B
OSG$223M
JPM is 3,999 times OSG
Revenue, 12 months
JPM$203B
OSG$339M
JPM is 599 times OSG
Net income, 12 months
JPM$66.0B
OSG-$60M
Operating margin
JPM–
OSG–
ROIC
JPM15.1%
OSG-5.2%
20.3 points apart
P/E
JPM13.8
OSG–
Dividend yield
JPM1.9%
OSG0.0%
1.9 points apart
5-year return
JPM+126.0%
OSG-71.6%
197.6 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
JPM+126.0%
OSG-71.7%
| Period | JPMWith dividends | OSGWith dividends |
|---|---|---|
| 1 year since November 14, 2025 | +10.8%Price +8.7% | -48.0%Price -48.0% |
| 3 years since November 17, 2023 | +130.1%+32.0% a yearPrice +115.9% | -65.8%-30.1% a yearPrice -65.8% |
| 5 years since November 16, 2021 | +126.0%+17.7% a yearPrice +99.5% | -71.6%-22.3% a yearPrice -71.6% |
| 10 years since November 18, 2016 | +451.0%+18.6% a yearPrice +324.6% | -78.7%-14.3% a yearPrice -78.7% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
JPMJP Morgan Chase & Co.OSGOctave Specialty
| Price | $329.96 | $4.95 |
|---|---|---|
| Market value | $890B | $223M |
| Enterprise value (EV) | – | $205M |
| P/E | 13.8 | – |
| P/E, 5-year median | 11.1 | – |
| P/B | 2.5 | 0.3 |
| EV/EBIT | – | – |
| Free cash flow yield | – | – |
| Revenue, 12 months | $203B | $339M |
|---|---|---|
| Net income, 12 months | $66.0B | -$60M |
| Free cash flow, 12 months | – | – |
| Earnings per share, 12 months | $23.85 | -$1.65 |
| Revenue growth, year on year | 2.8% | 6.5% |
| Revenue growth a year, past | +8.8%over 5 years | +10.0%over 5 years |
| EPS growth a year, past | +17.7%over 5 years | – |
| Gross margin | – | – |
|---|---|---|
| Operating margin | – | – |
| Net margin | 32.5% | -17.7% |
| ROIC | 15.1% | -5.2% |
| ROE | 18.0% | -8.2% |
| Cash | $1.11T | $173M |
|---|---|---|
| Total debt | $531B | $155M |
| Net debt / EBITDA | – | – |
| Interest cover | – | -6.6× |
| Dividend yield | 1.9% | – |
|---|---|---|
| Dividend per share, 12 months | $6.15 | – |
| Dividend growth a year, past | +10.0%over 5 years | – |
| Buyback yield | 3.6% | 13.5% |
| Shareholder yield | 5.4% | 13.5% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, JP Morgan Chase & Co. ($890B) is about 3,999.4 times Octave Specialty ($223M), at today's prices.
Since November 18, 2016, JPM's price moved +324.6% and OSG's -78.7%. With dividends: JPM +451.0% (+18.6% a year), OSG -78.7% (-14.3% a year). Past returns do not predict future ones.
The dividend yield at today's price is 1.86% for JP Morgan Chase & Co. and none for Octave Specialty. Over the last twelve months they paid $6.15 and – per share.
Over the last twelve months, the net margin was 32.5% for JP Morgan Chase & Co. and -17.7% for Octave Specialty, and the operating margin – and –. Revenue was $203B and $339M.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.